A two-year study uncovers potential immune biomarkers to detect long COVID, and evidence that its inflammatory symptoms may resolve over time.
Researchers have identified a stem cell marker that influences fat cell development, unlocking exciting therapeutic opportunities for chronic diseases.
A*STAR researchers identified immune markers that can distinguish between common febrile diseases in Saudi Arabia.
A new biomarker in liver tumor may help doctors predict how patients respond to immunotherapy.
New insights into the tumor microenvironment may help researchers stop the growth and spread of cancer to other parts of the body.
These novel immune signatures identify patients most at risk for developing severe COVID-19 symptoms.
A novel genomic biomarker may help to meet the demand for donor mesenchymal stem cells in regenerative medicine.
A*STAR scientists can now classify immune cell populations with greater precision thanks to a machine-learning algorithm.